Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.
- DOI
- 10.1016/j.bvth.2026.100200
- Published
- 2026 Nov
- Container
- Blood vessels, thrombosis & hemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bvth.2026.100200,
title = {Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.},
author = {Costa-Lima C and Faiotto VB and Francisco AP and Foschi NM and Medina SS and Colella MP and Lima Montalvão SA and Yamaguti-Hayakawa GG and Frade-Guanaes JO and Ozelo MC},
year = {2026},
journal = {Blood vessels, thrombosis \& hemostasis},
doi = {10.1016/j.bvth.2026.100200},
url = {https://doi.org/10.1016/j.bvth.2026.100200}
}RIS
TY - JOUR TI - Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A. AU - Costa-Lima C AU - Faiotto VB AU - Francisco AP AU - Foschi NM AU - Medina SS AU - Colella MP AU - Lima Montalvão SA AU - Yamaguti-Hayakawa GG AU - Frade-Guanaes JO AU - Ozelo MC PY - 2026 JO - Blood vessels, thrombosis & hemostasis DO - 10.1016/j.bvth.2026.100200 UR - https://doi.org/10.1016/j.bvth.2026.100200 ER -
APA
C, C., VB, F., AP, F., NM, F., SS, M., MP, C., SA, L. M., GG, Y., JO, F., & MC, O. (2026). Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.. Blood vessels, thrombosis & hemostasis. https://doi.org/10.1016/j.bvth.2026.100200
Source records
- pubmed · retrieved 2026-09-25T05:27:34.765Z